Hunter Jacob B, Smith Richard V, Brandwein-Gensler Margaret
Department of Otorhinolaryngology-Head Neck Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
Head Neck Pathol. 2008 Dec;2(4):316-23. doi: 10.1007/s12105-008-0082-1. Epub 2008 Sep 12.
Low-grade papillary adenocarcinoma (LGPA) represents a relatively rare histological variant of polymorphous low-grade adenocarcinoma (PLGA). There has been a debate as to whether LGPA is associated with greater aggressive potential compared to PLGA; this is further obfuscated by the fact that diagnostic criteria for LGPA have not been well-defined. We believe that this is the first report of a patient with LGPA who developed metastases to the femur and scalp. We review the published evidence for classifying LGPA as distinct from PLGA. The weight of published data does support the idea that LGPA is oncologically distinct from LGPA. However, as uniform diagnostic criteria are lacking, we suggest a cut-off value of 10% or greater papillary formation as being necessary to separate LGPA from PLGA.
低级别乳头状腺癌(LGPA)是多形性低级别腺癌(PLGA)中一种相对罕见的组织学变体。关于LGPA与PLGA相比是否具有更强的侵袭潜能一直存在争议;由于LGPA的诊断标准尚未明确界定,这一争议更加模糊不清。我们认为这是首例LGPA患者发生股骨和头皮转移的报告。我们回顾了将LGPA与PLGA区分开来的已发表证据。已发表数据的权重确实支持LGPA在肿瘤学上与PLGA不同的观点。然而,由于缺乏统一的诊断标准,我们建议以10%或更高的乳头状形成作为将LGPA与PLGA区分开来的必要临界值。